Description:

GOG-0249 Follow-Up Period Adverse Event Reporting Form Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4FF32E53-FBDD-394B-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4FF32E53-FBDD-394B-E044-0003BA3F9857

Keywords:
Versions (2) ▾
  1. 9/19/12
  2. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Endometrial Cancer NCT00807768 Toxicity - GOG-0249 Follow-Up Period Adverse Event Reporting Form - 2760083v1.0

No Instruction available.

  1. StudyEvent: GOG-0249 Follow-Up Period Adverse Event Reporting Form
    1. No Instruction available.
Header Module
Adverse Events - Section 1
Are there any adverse events to report
Were adverse events assessed during most recent period
Was patient hospitalized as a result of reported adverse events? (during this reporting period)
Adverse Events - Section 3
CTC Adverse Event Attribution Code (Attribution Codes for Relationship of Event to Treatment: 1=Unrelated, 2=Unlikely, 3=Possibly, 4=Probably, 5=Definitely)
SAE report submitted
Present Status
Comments

Similar models